The Journal of Nutritional Biochemistry
Volume 21, Issue 2 , Pages 125-132 , February 2010

Bioactivity of nitrolinoleate: effects on adhesion molecules and CD40–CD40L system

  • Luciane A. Faine

      Affiliations

    • Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of São Paulo, Sao Paulo 05508-900, Brazil
    • Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid 28029, Spain
    • ,
  • Danielle M.H. Cavalcanti

      Affiliations

    • Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of São Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • Martina Rudnicki

      Affiliations

    • Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of São Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • Simone Ferderbar

      Affiliations

    • Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of São Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • Sandra M.D. Macedo

      Affiliations

    • Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of São Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • Heraldo P. Souza

      Affiliations

    • Emergency Medicine Research Laboratory, University of São Paulo, Sao Paulo 01246-903, Brazil
    • ,
  • Sandra H.P. Farsky

      Affiliations

    • Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of São Paulo, Sao Paulo 05508-900, Brazil
    • ,
  • Lisardo Boscá

      Affiliations

    • Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM), Madrid 28029, Spain
    • ,
  • Dulcineia Saes Parra Abdalla

      Affiliations

    • Faculty of Pharmaceutical Sciences, Department of Clinical and Toxicological Analyses, University of São Paulo, Sao Paulo 05508-900, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 11 30913637; fax: +55 11 38132197.

Received 12 August 2008 ,Revised 3 November 2008 ,Accepted 1 December 2008.

References 

  1. Lip GYH, Patel JV, Hughes E, Hart RG. High-sensitivity C-Reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation. Stroke. 2007;38(4):1229–1237
  2. Phipps RP. Atheroclerosis: the emerging role of inflammation and the CD40–CD40 ligand system. PNAS. 2000;97:6030–6032
  3. Aukrust P, Muller F, Ueland T, Berget T, Aaser E, Brunsvig A, et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Circulation. 1999;100:614–620
  4. Urbich C, Dernbach E, Aicher A, Zeiher AM, Dimmeler S. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation. 2002;106:981–986
  5. Kotowicz K, Dixon GLJ, Klein NJ, Peters MJ, Callard RE. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes. Immunology. 2000;100:441–448
  6. Adawi A, Zhanga Y, Baggs R, Rubind P, Williamsd J, Finkelstein J, et al. Blockade of CD40–CD40 ligand interactions protects against radiation-induced pulmonary inflammation and fibrosis. Clin Immunol Immunopathol. 1998;89(3):222–230
  7. Mach F, Schoenbeck U, Sukhova G, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signaling. Nature. 1998;394:200–203
  8. Jiang MZ, Tsukahara H, Ohshima Y, Todoroki Y, Hiraoka M, Maeda M, et al. Effects of antioxidants and nitric oxide on TNF-alpha induced adhesion molecule expression and NF-kappa B activation in human dermal microvascular endothelial cells. Life Sci. 2004;75(10):1159–1170
  9. Moreno SE, Alves-Filho JC, Bertozi G, Alfaya TM, Theze J, Ferreira SH, et al. Systemic administration of interleukin-2 inhibits inflammatory neutrophil migration: role of nitric oxide. Brit J Pharmacol. 2006;148(8):1060–1066
  10. Rekka EA, Chrysselis MC. Nitric oxide in atherosclerosis. Mini Rev Med Chem. 2002;2(6):585–593
  11. O'Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res. 2001;88(1):12–21
  12. Lima ES, Di Mascio P, Rubbo H, Abdalla DS. Characterization of linoleic acid nitration in human blood plasma by mass spectrometry. Biochem. 2002;41(34):10717–10722
  13. Lima ES, Bonini MG, Augusto O, Barbeiro HV, Souza HP, Abdalla DS. Nitrated lipids decompose to nitric oxide and lipid radicals and cause vasorelaxation. Free Rad Biol Med. 2005;39(4):532–539
  14. Coles B, Bloodsworth A, Clark SR, Lewis MJ, Cross AR, Freeman BA, et al. Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ Res. 2002;91(5):375–381
  15. Schopfer FJ, Lin Y, Baker PR, Cui T, Garcia-Barrio M, Zhang J, et al. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc Natl Acad Sci U S A. 2005;102(7):2340–2345
  16. Napoli C, Cirino G, Del SP, Sorrentino R, Sica V, Condorelli M, et al. Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice. Proc Natl Acad Sci U S A. 2001;98(5):2860–2864
  17. Krieger MH, Santos KF, Shishido SM, Wanschel AC, Estrela HF, Santos L, et al. Antiatherogenic effects of S-nitroso-N-acetylcysteine in hypercholesterolemic LDL receptor knockout mice. Nitric Oxide. 2006;14(1):12–20
  18. Shopfer FJ, Baker PRS, Giles G, Chumley P, Batthyany C, Crawford J, et al. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid is hidrofobically stabilized nitric oxide donor. J Biol Chem. 2005;280(19):19289–19297
  19. Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO?. J Leukoc Biol. 1995;58(6):643–649
  20. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, et al. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem. 1998;70(13):2446–2453
  21. Jaffrey SR, Snyder SH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE. 2001;86:PL1
  22. Farsky SP, Sannomiya P, Garcia-Leme J. Secreted glucocorticoids regulate leukocyte-endothelial interactions in inflammation. A direct vital microscopic study. J Leukoc Biol. 1995;57(3):379–386
  23. Farsky SH, Borelli P, Fock RA, Proto SZ, Ferreira JM, Mello SB. Chronic blockade of nitric oxide biosynthesis in rats: effect on leukocyte endothelial interaction and on leukocyte recruitment. Inflam Res. 2004;53(9):442–452
  24. Chen SF, Fei X, Li SH. A simple method for isolation of microvascular endothelial cells avoiding both chemical and mechanical injuries. Microvasc Res. 1995;50(1):119–128
  25. Cavalcanti DMH, Lotufo CMC, Borelli P, Tavassi AMC, Pereira ALM, Markus RP, et al. Adrenal deficiency alters mechanisms of neutrophils mobilization. Mol Cell Endocrinol. 2006;249(1-2):32–39
  26. Lima ES, Di Mascio P, Abdalla DS. Cholesteryl nitrolinoleate, a nitrated lipid present in human blood plasma and lipoproteins: Synthesis, characterization, and detection by HPLC coupled to mass spectrometry. J Lipid Res. 2003;44(9):1660–1666
  27. Lei XF, Ohkawara Y, Stämpfli MR, Mastruzzo C, Marr RA, Snider D, et al. Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice. J Clin.Invest. 1998;101(6):1342–1353
  28. Sasaki M, Jordan P, Welbourne T, Minagar A, Joh T, Itoh M, et al. Troglitazone, a PPARγ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α. Biomed Central Physiol. 2005;5(1):1–12
  29. Jackson SM, Parhami F, Xi XP, Berliner JA, Hsueh WA, Law RE, et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol. 1999;19:2094–2104
  30. Chen NG, Han X. Dual function of troglitazone in ICAM-1 gene expression in human vascular endothelium. Biochem Biophys Res Comm. 2001;282(1):217–221
  31. Cui T, Schopfer FJ, Zhang J, Chen K, Ichikawa T, Baker PR, et al. Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators. J Biol Chem. 2006;281(47):35686–35698
  32. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88(11):4651–4655
  33. Banick PD, Chen Q, Xu YA, Thom SR. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis. J Cell Physiol. 1997;172(1):12–24
  34. Douglass WA, Hyland RH, Buckley CD, Al-Shamkhani A, Shaw JM, Scarth SL, et al. The role of the cysteine-rich region of the beta2 integrin subunit in the leukocyte function-associated antigen-1 (LFA-1, alphaLbeta2, CD11a/CD18) heterodimer formation and ligand binding. FEBS Lett. 1998;440(3):414–418
  35. Tan SM, Walters SE, Mathew EC, Robinson MK, Drbal K, Shaw JM, et al. Defining the repeating elements in the cysteine-rich region (CRR) of the CD18 integrin beta 2 subunit. FEBS Lett. 2001;505(1):27–30

☆ This study was supported by Fundação de Apoio à Pesquisa do Estado de São Paulo and Conselho Nacional de Desenvolvimento Científico e Tecnológico/Instituto do Milênio-Redoxoma. We thank Dr. Rui Curi and Mr. Marco Aurélio Ramirez for the flow cytometry analysis.

PII: S0955-2863(08)00253-2

doi: 10.1016/j.jnutbio.2008.12.004

The Journal of Nutritional Biochemistry
Volume 21, Issue 2 , Pages 125-132 , February 2010

Article Tools

* Image Usage & Resolution